RA CAPITAL MANAGEMENT, L.P.
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
84 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.9% | $9,418,368,368 |
| Financial Services | 0.1% | $12,700,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | +8,772,496 | 26,975,505 | $195,572,411 | |
| ABOS | Acumen Pharmaceuticals, Inc. | +6,060,606 | 20,992,669 | $49,542,698 | |
| SLDB | Solid Biosciences Inc. | +3,528,555 | 9,339,978 | $67,247,841 | |
| DSGN | Design Therapeutics, Inc. | +1,511,592 | 2,972,973 | $31,632,432 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +1,000,000 | 2,611,733 | $219,176,633 | |
| PCVX | Vaxcyte, Inc. | +750,000 | 11,474,599 | $666,788,947 | |
| NUVL | Nuvalent, Inc. | +654,088 | 2,534,145 | $259,623,155 | |
| IRON | Disc Medicine, Inc. | +474,089 | 2,450,221 | $156,667,130 | |
| WAY | Waystar Holding Corp. | +385,000 | 529,400 | $12,763,834 | |
| MLYS | Mineralys Therapeutics, Inc. | +369,000 | 7,692,750 | $208,396,597 | |
| BCAX | Bicara Therapeutics Inc. | +300,000 | 7,255,993 | $144,321,700 | |
| HNGE | Hinge Health, Inc. | +284,500 | 364,613 | $14,059,477 | |
| ACET | Adicet Bio, Inc. | +234,375 | 1,182,624 | $8,053,669 | |
| INSP | Inspire Medical Systems, Inc. | +183,699 | 325,663 | $16,797,697 | |
| WGS | GeneDx Holdings Corp. | +151,843 | 209,887 | $13,478,943 | |
| EVMN | Evommune, Inc. | +35,868 | 3,494,638 | $80,341,727 | |
| CLYM | Climb Bio, Inc. | +7,111 | 11,300,939 | $77,411,431 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 8,021,117 | $207,827,141 | |
| ZLAB | Zai Lab Ltd | 5,707,262 | $107,353,598 | |
| SRPT | Sarepta Therapeutics, Inc. | 3,902,596 | $84,920,488 | |
| DMRA | Damora Therapeutics, Inc. | 2,399,310 | $62,142,129 | |
| XNCR | Xencor Inc | 4,897,237 | $59,060,678 | |
| IPSC | Century Therapeutics, Inc. | 17,754,430 | $40,125,011 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 318,554 | $29,428,018 | |
| BIOA | BioAge Labs, Inc. | 1,650,648 | $28,869,833 | |
| AKTS | Aktis Oncology, Inc. | 1,503,084 | $26,890,172 | |
| ALXO | Alx Oncology Holdings Inc | 13,011,849 | $26,088,757 | |
| ACRS | Aclaris Therapeutics, Inc. | 6,804,072 | $25,515,270 | |
| TVTX | Travere Therapeutics, Inc. | 746,841 | $22,188,646 | |
| RLMD | Relmada Therapeutics, Inc. | 2,947,369 | $20,513,688 | |
| DRUG | Bright Minds Biosciences Inc. | 265,000 | $19,337,050 | |
| STRO | Sutro Biopharma, Inc. | 715,307 | $17,818,297 | |
| AVR | Anteris Technologies Global Corp. | 3,000,000 | $16,650,000 | |
| OKUR | OnKure Therapeutics, Inc. | 3,998,333 | $16,553,098 | |
| HLXC | Helix Acquisition Corp. III | 1,250,000 | $12,700,000 | |
| RNA | Atrium Therapeutics, Inc. | 864,102 | $11,553,043 | |
| KPTI | Karyopharm Therapeutics Inc. | 1,917,354 | $10,679,661 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 450,000 | $6,583,500 | |
| EQ | Equillium, Inc. | 3,096,336 | $6,192,672 | |
| MGNX | Macrogenics Inc | 1,864,176 | $5,387,468 | |
| MPLT | MapLight Therapeutics, Inc. | 248,294 | $5,047,817 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 1,267,156 | $82,618,571 | |
| BLTE | Belite Bio, Inc | 432,484 | $69,180,140 | |
| IVVD | Invivyd, Inc. | 17,119,096 | $42,284,167 | |
| MDLN | Medline Inc. | 335,000 | $14,070,000 | |
| PGNY | Progyny, Inc. | 96,628 | $2,481,407 | |
| KIDS | Orthopediatrics Corp | 109,959 | $1,952,871 | |
| HCAT | Health Catalyst, Inc. | 793,749 | $1,897,060 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 10,281,496 | $2,351,686,580 | 24.94% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 11,474,599 | $666,788,947 | 7.07% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Held | 6,666,837 | $579,814,813 | 6.15% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 12,198,625 | $467,207,337 | 4.95% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 9,905,045 | $397,093,254 | 4.21% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 10,428,437 | $328,495,765 | 3.48% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 9,550,191 | $305,701,613 | 3.24% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 2,534,145 | $259,623,155 | 2.75% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 2,611,733 | $219,176,633 | 2.32% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 7,692,750 | $208,396,597 | 2.21% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
NEW | 8,021,117 | $207,827,141 | 2.20% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Added | 26,975,505 | $195,572,411 | 2.07% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 6,995,858 | $168,110,467 | 1.78% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 2,450,221 | $156,667,130 | 1.66% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 11,189,693 | $155,536,732 | 1.65% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Held | 15,827,186 | $150,674,810 | 1.60% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 7,255,993 | $144,321,700 | 1.53% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 373,787 | $120,430,433 | 1.28% | |
| GHRS |
GH Research PLC
Healthcare
|
Held | 7,676,697 | $107,934,359 | 1.14% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
NEW | 5,707,262 | $107,353,598 | 1.14% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Held | 23,555,648 | $105,293,746 | 1.12% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 5,404,998 | $96,425,164 | 1.02% | |
| GERN |
Geron Corp
Healthcare
|
Held | 63,771,366 | $95,019,335 | 1.01% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Held | 10,860,977 | $87,213,645 | 0.92% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
NEW | 3,902,596 | $84,920,488 | 0.90% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 1,621,620 | $81,794,512 | 0.87% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 3,494,638 | $80,341,727 | 0.85% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Added | 11,300,939 | $77,411,431 | 0.82% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 9,339,978 | $67,247,841 | 0.71% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
Held | 9,853,302 | $63,455,264 | 0.67% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 2,399,310 | $62,142,129 | 0.66% | |
| XNCR |
Xencor Inc
Healthcare
|
NEW | 4,897,237 | $59,060,678 | 0.63% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 2,208,604 | $54,464,174 | 0.58% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 3,671,083 | $51,578,716 | 0.55% | |
| ABOS |
Acumen Pharmaceuticals, Inc.
Healthcare
|
Added | 20,992,669 | $49,542,698 | 0.53% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 5,049,779 | $47,013,442 | 0.50% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Held | 6,053,960 | $46,433,873 | 0.49% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Held | 1,507,844 | $45,838,457 | 0.49% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 17,754,430 | $40,125,011 | 0.43% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 2,600,000 | $38,766,000 | 0.41% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Held | 4,178,823 | $38,236,230 | 0.41% | |
| MNPR |
Monopar Therapeutics
Healthcare
|
Held | 667,207 | $36,556,271 | 0.39% | |
| PEPG |
PepGen Inc.
Healthcare
|
Held | 20,064,545 | $35,514,244 | 0.38% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Added | 2,972,973 | $31,632,432 | 0.34% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
NEW | 318,554 | $29,428,018 | 0.31% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 1,650,648 | $28,869,833 | 0.31% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Held | 5,000,000 | $28,700,000 | 0.30% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 1,020,410 | $28,316,377 | 0.30% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 9,180,000 | $27,999,000 | 0.30% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 1,503,084 | $26,890,172 | 0.29% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.